Beyang Therapeutics

Aiming to be the "DreamWorks" of drug discovery

Shanghai, China · Founded 2021 · $30.0M raised

Headquarters
Shanghai
Founded
2021
Business Model
B2B
Total Funding
$30.0M
Last Round
Venture RoundAug 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Beyang Therapeutics is an AI-driven innovative drug R&D company, aiming to become the "DreamWorks" of innovative drug discovery. The company focuses on developing drugs with clear mechanisms of action and high potential for clinical translation in areas with unmet medical needs. Based on its proprietary ExCEED platform, which integrates proprietary databases with AI and computational simulation across molecular design, druggability optimization, and biological evaluation, Beyang boasts industry-leading preclinical pipeline conversion rates. Its core team includes scientists from Pfizer, Merck, and Hengrui who have advanced over 10 projects into clinical trials.

Summary

Beyang Therapeutics is an Artificial Intelligence company based in Shanghai, China, founded in 2021. It has raised $30.0M in total across 2 rounds, most recently a Venture Round in Aug 2026. Investors include Legend Capital and Shanghai Healthcare Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AAug 2026
$30.0M

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series FTotal funding$3.8BJan 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Beyang Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/beyang-therapeutics"><img src="https://indexed.vc/api/badge/company/beyang-therapeutics" alt="Beyang Therapeutics on Indexed.vc" width="260" height="76" /></a>